Current Edition

cancer

Novartis aims to keep canakinumab’s early lung cancer hopes alive despite metastatic failure

When Novartis failed in an attempt to repurpose Ilaris for metastatic non-small cell lung cancer (NSCLC), the Swiss pharma played up signs that it said …

Continue Reading →
Bayer

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Since it was established in 2017, Cellino Biotech has offered an intriguing approach to stem cell therapy manufacturing, combining biology, laser physics, gene editing tools …

Continue Reading →
cancer

ASH: Senti Bio’s gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models

Engineered cell therapy has revolutionized the treatment of blood cancers, but precisely selecting the right target to kill off cancer cells while sparing healthy cells …

Continue Reading →
byproduct

PROSTATE CANCER DRUG BYPRODUCT CAN FUEL CANCER CELLS, UNITED STATES-BASED RESEARCHERS FIND

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research …

Continue Reading →
bolster

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together …

Continue Reading →
cell

Stem cell symposium to highlight clinical trials, safety and regulation

Twenty years ago this fall, a team of scientists led by James Thomson at the University of Wisconsin–Madison published the first paper describing successful derivation …

Continue Reading →